A different study conducted by Elias et al. showed that aberrant methylation of HOXA4 and HOXA5 has been associated with imatinib resistance in CML patients [43], thus confirming that the hypermethylation of these genes correlates with a poor prognosis outcome. Here, HOXA4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.